Common Contracts

Indicates portions of this exhibit that have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. EXECUTION VERSION RIGHT TO SUBLICENSE AGREEMENT

Right to Sublicense Agreement • May 5th, 2020 • Delaware

• Contract Type
  Right to Sublicense Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Delaware

This Right to Sublicense Agreement (“Agreement”) is made and entered into as of October 27, 2017 by and between Baxalta Incorporated, Baxalta US Inc., and Baxalta GmbH (collectively, with their Affiliates, “Baxalta”) and Xenetic Biosciences, Inc. (with its Affiliates, “Xenetic”) (with Baxalta and Xenetic being the “Parties” and each individually, a “Party”).

RIGHT TO SUBLICENSE AGREEMENT

Right to Sublicense Agreement • March 30th, 2018 • Xenetic Biosciences, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Right to Sublicense Agreement
• Filed
  March 30th, 2018
• Company
  Xenetic Biosciences, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Right to Sublicense Agreement (“Agreement”) is made and entered into as of October 27, 2017 by and between Baxalta Incorporated, Baxalta US Inc., and Baxalta GmbH (collectively, with their Affiliates, “Baxalta”) and Xenetic Biosciences, Inc. (with its Affiliates, “Xenetic”) (with Baxalta and Xenetic being the “Parties” and each individually, a “Party”).